LSP1P5,CEBPA keloids ,

Shuchen Gu1, Xin Huang1, Shenying Luo1

  • 1Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, 639 Zhizaoju Road, Shanghai 200011, P.R. China.

概括

这项研究确定了淋巴细胞特异性蛋白1伪基因5 (LSP1P5) 作为 keloid 病原发生的关键调节者. 向LSP1P5提供了一种新的治疗策略,通过表观遗传控制CCAAT增强剂结合蛋白α (CEBPA) 来减少纤维化.